[go: up one dir, main page]

GB0723338D0 - Prognostic assay - Google Patents

Prognostic assay

Info

Publication number
GB0723338D0
GB0723338D0 GBGB0723338.0A GB0723338A GB0723338D0 GB 0723338 D0 GB0723338 D0 GB 0723338D0 GB 0723338 A GB0723338 A GB 0723338A GB 0723338 D0 GB0723338 D0 GB 0723338D0
Authority
GB
United Kingdom
Prior art keywords
prognostic assay
prognostic
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0723338.0A
Other versions
GB2455108A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Niox Healthcare Ltd
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Circassia Ltd filed Critical Circassia Ltd
Priority to GB0723338A priority Critical patent/GB2455108A/en
Publication of GB0723338D0 publication Critical patent/GB0723338D0/en
Publication of GB2455108A publication Critical patent/GB2455108A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/505Cells of the immune system involving T-cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
GB0723338A 2007-11-28 2007-11-28 T-Cell dependent method for detecting non-allergic or intrinsic disorders Withdrawn GB2455108A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0723338A GB2455108A (en) 2007-11-28 2007-11-28 T-Cell dependent method for detecting non-allergic or intrinsic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0723338A GB2455108A (en) 2007-11-28 2007-11-28 T-Cell dependent method for detecting non-allergic or intrinsic disorders

Publications (2)

Publication Number Publication Date
GB0723338D0 true GB0723338D0 (en) 2008-01-09
GB2455108A GB2455108A (en) 2009-06-03

Family

ID=38962290

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0723338A Withdrawn GB2455108A (en) 2007-11-28 2007-11-28 T-Cell dependent method for detecting non-allergic or intrinsic disorders

Country Status (1)

Country Link
GB (1) GB2455108A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009022157A2 (en) 2007-08-15 2009-02-19 Circassia Limited Peptide with improved solubility
JP5871819B2 (en) * 2010-01-14 2016-03-01 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Allergen Group 5 Allergen Variants with Allergenicity Reduced by Mutation of Proline Residues
GB201208293D0 (en) * 2012-05-11 2012-06-20 Circassia Ltd Hydrochlorice salt of peptide
EP3964232A1 (en) 2012-10-30 2022-03-09 Aravax Pty Ltd Novel immunotherapeutic molecules and uses thereof
AU2014328483B2 (en) 2013-09-25 2019-11-14 Aravax Pty Ltd Novel immunotherapeutic composition and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180368B1 (en) * 1988-03-23 2001-01-30 University Of Melbourne Ryegrass pollen allergen
US7288256B1 (en) * 1991-10-16 2007-10-30 Merck Patent Gmbh T cell epitopes of the major allergens from dermatophagoides (house dust mite)
AU682658B2 (en) * 1991-10-16 1997-10-16 Merck Patent Gmbh Recombitope peptides
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
EP1241476A1 (en) * 2001-03-12 2002-09-18 Mabtech AB Diagnosis of metal allergy through cytokine release by T-cells in vitro
AU2003902792A0 (en) * 2003-06-03 2003-06-19 Advanced Diagnostic Systems Pty Ltd A method for early detection of allergic sensitisation
AU2005247049A1 (en) * 2004-05-27 2005-12-08 Novozymes Biopharma Au Limited Treatment of inflammatory airway disease

Also Published As

Publication number Publication date
GB2455108A (en) 2009-06-03

Similar Documents

Publication Publication Date Title
HK1134917A1 (en) Assays
ZA201000845B (en) Assays
HK1189937A1 (en) Distinguishing assay
GB0713930D0 (en) Novel assay methods
GB201001079D0 (en) Prognostic assay
GB0723338D0 (en) Prognostic assay
GB0811567D0 (en) Assay
GB0807534D0 (en) Assay
GB0803850D0 (en) Assay
GB0811858D0 (en) Assay
GB0809262D0 (en) Assay
GB0608446D0 (en) Assay
GB0814591D0 (en) Assay
GB0615813D0 (en) Assay
GB0822010D0 (en) Assay
GB0821624D0 (en) Assay
GB0600031D0 (en) Assay
GB0623892D0 (en) Assay
GB0607462D0 (en) Assay
GB0722378D0 (en) Prognostic assay
GB0715386D0 (en) Assay
GB0719757D0 (en) Assay
GB0715725D0 (en) Assay
GB0711955D0 (en) Assay
GB0721944D0 (en) Assay

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)